{ "cik": 1390478, "cik_padded": "0001390478", "entityName": "SELLAS Life Sciences Group, Inc.", "fiscal_years": [ { "accn": "0001390478-26-000003", "filed": "2026-03-19", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 71793000.0, "eps_diluted": -0.25, "net_income": -26863000.0, "operating_cash_flow": -28389000.0, "operating_income": -28274000.0, "stockholders_equity": 70871000.0, "total_assets": 78345000.0, "total_liabilities": 7474000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.10545921462939707, "roa_avg2y": -0.549474825367929, "roa_period_end": -0.3428808475333461, "roe_avg2y": -0.6687661820354511, "roe_period_end": -0.37904079242567484 } }, { "accn": "0001390478-26-000003", "filed": "2026-03-19", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 13886000.0, "eps_diluted": -0.5, "net_income": -30881000.0, "operating_cash_flow": -35402000.0, "operating_income": -31513000.0, "stockholders_equity": 9465000.0, "total_assets": 19432000.0, "total_liabilities": 9967000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.0530375066032753, "roa_avg2y": -2.4077813730458852, "roa_period_end": -1.5891827912721284, "roe_avg2y": -41.478844862323704, "roe_period_end": -3.262651875330164 } }, { "accn": "0001390478-26-000003", "filed": "2026-03-19", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 2530000.0, "eps_diluted": -1.34, "net_income": -37340000.0, "operating_cash_flow": -31410000.0, "operating_income": -37869000.0, "stockholders_equity": -7976000.0, "total_assets": 6219000.0, "total_liabilities": 14195000.0 }, "period_end": "2023-12-31", "ratio_units": { "roa_avg2y": "ratio", "roe_avg2y": "ratio" }, "ratios": { "roa_avg2y": -2.749429349826964, "roe_avg2y": 23.8976 } }, { "accn": "0001390478-25-000003", "filed": "2025-03-20", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 17125000.0, "eps_diluted": -2.13, "net_income": -41301000.0, "operating_cash_flow": -23809000.0, "operating_income": -41950000.0, "stockholders_equity": 4851000.0, "total_assets": 20943000.0, "total_liabilities": 16092000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "leverage": 3.3172541743970316, "roa_avg2y": -1.749375238256597, "roa_period_end": -1.9720670391061452, "roe_avg2y": -3.27811731089769 } }, { "accn": "0001390478-24-000004", "filed": "2024-03-28", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 21355000.0, "eps_diluted": -1.34, "net_income": -20699000.0, "operating_cash_flow": -26021000.0, "operating_income": -25294000.0, "stockholders_equity": 20347000.0, "total_assets": 26275000.0, "total_liabilities": 5928000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.29134516144886224, "roa_avg2y": -0.5723964382500968, "roa_period_end": -0.7877830637488107, "roe_avg2y": -0.8569595098120394, "roe_period_end": -1.0172998476433872 } }, { "accn": "0001390478-23-000005", "filed": "2023-03-16", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "cash": "USD", "eps_diluted": "USD/shares", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 35302000.0, "eps_diluted": -2.11, "net_income": -16757000.0, "operating_cash_flow": -10417000.0, "operating_income": -16982000.0, "stockholders_equity": 27961000.0, "total_assets": 46049000.0, "total_liabilities": 18088000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.6469010407353099, "roa_avg2y": -0.5348718439784226, "roa_period_end": -0.36389498143282156, "roe_avg2y": -0.9841428319727492, "roe_period_end": -0.5992990236400701 } }, { "accn": "0001390478-22-000006", "filed": "2022-03-31", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 7277000.0, "net_income": -19292000.0, "operating_cash_flow": -17643000.0, "operating_income": -20041000.0, "stockholders_equity": 6093000.0, "total_assets": 16609000.0, "total_liabilities": 10516000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.7259149844083375, "roa_avg2y": -1.1509366424054408, "roa_period_end": -1.1615389246793908, "roe_avg2y": -3.403069324395837, "roe_period_end": -3.166256359757098 } }, { "accn": "0001390478-21-000007", "filed": "2021-03-23", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 5337000.0, "net_income": -27670000.0, "operating_cash_flow": -30422000.0, "stockholders_equity": 5245000.0, "total_assets": 16915000.0, "total_liabilities": 11670000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "leverage": 2.224976167778837, "roa_avg2y": -1.0971233718601932, "roa_period_end": -1.6358261897723911, "roe_avg2y": -7.565276828434723 } }, { "accn": "0001390478-19-000017", "filed": "2019-03-22", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 2319000.0, "net_income": -23754000.0, "operating_cash_flow": -10989000.0, "operating_income": -23039000.0, "stockholders_equity": 2070000.0, "total_assets": 33526000.0, "total_liabilities": 31456000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio" }, "ratios": { "leverage": 15.196135265700484, "roa_avg2y": -1.1893055625093876, "roa_period_end": -0.7085247270774921, "roe_avg2y": 16.230953194396992 } }, { "accn": "0001193125-18-117053", "filed": "2018-04-13", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "cash": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "cash": 5962000.0, "net_income": -17681000.0, "operating_cash_flow": -11850000.0, "operating_income": -15988000.0, "stockholders_equity": -4997000.0, "total_assets": 6420000.0, "total_liabilities": 11417000.0 }, "period_end": "2016-12-31", "ratios": {} }, { "accn": "0001390478-17-000020", "filed": "2017-03-15", "fiscal_year": 2015, "form": "10-K", "fundamental_units": { "operating_income": "USD" }, "fundamentals": { "operating_income": -34220000.0 }, "period_end": "2015-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001390478-26-000003", "filed": "2026-03-19", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001390478.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001390478.json" }, "ticker": "SLS" }